Novo Nordisk's once-weekly insulin to be reviewed in the U.S. on May 24
Novo Nordisk’s weekly insulin, icodec, will be reviewed by the U.S. Food and Drug Administration (FDA) on May 24, Bloomberg reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
CHMP recommends new once-weekly insulin from Novo Nordisk
For subscribers